Compound details
Senaetnine
| Compound ID | CDAMM01075 |
|---|---|
| Common name | Senaetnine | IUPAC name | 2-hydroxy-N-[1-(8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl)-3-methylbutyl]-2-(5-oxo-2H-furan-2-yl)acetamide |
| Molecular formula | C20H23NO7 |
| Retention time | 0.42 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 390.156 | Theoretical mz | 390.154 |
| Error | 4.42 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.7549 |
| Inchi key | NTGIQQBAUYBEBF-ZTSOJENZNA-N |
|---|---|
| Smiles | O=C1OC(C=C1)C(O)C(=O)NC(CC(C)C)C2OC(=O)C=3C(O)=CC=CC3C2 |
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T98269 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P29466 | CASP1 |
| T98269 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | P29466 | CASP1 |
| T98269 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P29466 | CASP1 |
| T98269 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P29466 | CASP1 |
| T57943 | DI0060 | Brain cancer | [ICD-11: 2A00] | P42574 | CASP3 |
| T15700 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | Q9UQ81 | MCH5 |
| T15700 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UQ81 | MCH5 |